DK0784055T3 - Pyrimidinylpyrazolderivater - Google Patents

Pyrimidinylpyrazolderivater

Info

Publication number
DK0784055T3
DK0784055T3 DK95932229T DK95932229T DK0784055T3 DK 0784055 T3 DK0784055 T3 DK 0784055T3 DK 95932229 T DK95932229 T DK 95932229T DK 95932229 T DK95932229 T DK 95932229T DK 0784055 T3 DK0784055 T3 DK 0784055T3
Authority
DK
Denmark
Prior art keywords
group
hydrogen atom
chem
formula
pyrimidinylpyrazole
Prior art date
Application number
DK95932229T
Other languages
Danish (da)
English (en)
Inventor
Akio Daiichi Pharmaceuti Ejima
Masamichi Daiichi Pha Sugimori
Ikuo Daiichi Pharmaceut Mitsui
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0784055T3 publication Critical patent/DK0784055T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95932229T 1994-09-26 1995-09-25 Pyrimidinylpyrazolderivater DK0784055T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22942294 1994-09-26
JP13501095 1995-06-01
PCT/JP1995/001934 WO1996010024A1 (fr) 1994-09-26 1995-09-25 Derive pyrimidinylpyrazole

Publications (1)

Publication Number Publication Date
DK0784055T3 true DK0784055T3 (da) 2003-06-02

Family

ID=26468965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932229T DK0784055T3 (da) 1994-09-26 1995-09-25 Pyrimidinylpyrazolderivater

Country Status (13)

Country Link
US (1) US5852019A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0784055B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100388568B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1071754C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE232528T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2201110A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE69529619D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0784055T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2192584T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI971227A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO313196B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1996010024A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
CA2278677A1 (en) * 1997-01-27 1998-07-30 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
WO2000005230A1 (fr) * 1998-07-24 2000-02-03 Daiichi Pharmaceutical Co., Ltd. Derives de pyrazole et sels correspondants
AU3078000A (en) * 1999-01-25 2000-08-07 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compounds and antitumor agents containing the same as the active ingredient
CN1310907C (zh) 2001-04-27 2007-04-18 全药工业株式会社 杂环化合物和以其为有效成分的抗肿瘤药
WO2003011837A1 (en) * 2001-08-01 2003-02-13 Merck & Co., Inc. Tyrosine kinase inhibitors
US20050130989A1 (en) * 2003-01-28 2005-06-16 Aventis Pharma S. A. N-arylheteroaromatic products compositions containing them and use thereof
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
BRPI0407088A (pt) * 2003-01-28 2006-01-24 Aventis Pharma Sa Produtos n-aril-heteroaromáticos, composições contendo os mesmos e seu uso
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
JP4733021B2 (ja) * 2004-03-31 2011-07-27 全薬工業株式会社 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤
CN101137382B (zh) 2005-03-11 2012-11-21 全药工业株式会社 含有杂环化合物作为活性成分的免疫抑制剂和抗肿瘤剂
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
CA2675511A1 (en) 2006-10-10 2008-04-17 Amgen Inc. N-aryl pyrazole compounds for use against diabetes
EP3285581B1 (en) 2015-03-26 2021-08-11 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as pde2 inhibitors
ES2969565T3 (es) 2015-09-30 2024-12-13 Max Planck Ges Zur Foerderung Derwissenschaften E V Derivados heteroarílicos como inhibidores de la sepiapterina reductasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS4842072A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-09-29 1973-06-19
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
US5852019A (en) 1998-12-22
TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-08-11
DE69529619T2 (de) 2003-12-18
EP0784055B1 (en) 2003-02-12
EP0784055A1 (en) 1997-07-16
CN1166833A (zh) 1997-12-03
CN1071754C (zh) 2001-09-26
ES2192584T3 (es) 2003-10-16
EP0784055A4 (en) 1998-01-07
FI971227L (fi) 1997-05-23
NO313196B1 (no) 2002-08-26
DE69529619T4 (de) 2005-01-27
NO971384L (no) 1997-05-23
HK1001396A1 (en) 1998-06-19
DE69529619D1 (en) 2003-03-20
FI971227A0 (fi) 1997-03-24
KR970706275A (ko) 1997-11-03
WO1996010024A1 (fr) 1996-04-04
NO971384D0 (no) 1997-03-24
KR100388568B1 (ko) 2003-10-04
CA2201110A1 (en) 1996-04-04
FI971227A7 (fi) 1997-05-23
ATE232528T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
BE2018C008I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
ES2164241T3 (es) Compuestos pentaciclicos.
DK0784055T3 (da) Pyrimidinylpyrazolderivater
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ATE248814T1 (de) 16-ene-vitamin d derivate
ATE210642T1 (de) 2-substituierte vitamin-d3-derivate
DE60223227D1 (de) BenzoÄbÄthiophenderivate und Verfahren zu deren Herstellung
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
DE69828087D1 (de) Aminderivate
ATE140919T1 (de) Indolderivate
ATE189813T1 (de) Prostaglandin-i-analoga
EP1466900A4 (en) DERIVATIVES OF VITAMIN D-DOUBLE SUBSTITUTION
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.